Branded Legacy, Inc. signs letter of intent to purchase Sycamore BioPharma, LLC, to strengthen its position in the BioTech industry
Acquiring Company
Branded Legacy
Acquired Company
Sycamore Biopharma
MelbourneCanal Name Not AvailableManufacturingBiotechnologyHealth CareBiotechnologyHealth CareDietary SupplementsDescription
Branded Legacy, Inc., a leading BioTech holdings company, has announced the signed letter of intent to purchase Sycamore BioPharma, LLC, a developer of plant-based pharmaceuticals. This strategic move reinforces Branded Legacy's commitment to expanding its portfolio in the biotech sector and solidifying its position as a key player in the industry.
Other recent acquisitions in Dietary Supplements and Manufacturing
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Nuvation Bio Inc. completes acquisition of AnHeart Therapeutics Ltd. to enhance its oncology pipeline (April 10, 2024)
- Henry Schein completes acquisition of Majority Interest of TriMed, Inc. to strengthen orthopedic solutions (April 4, 2024)
- Nuvation Bio to Acquire AnHeart Therapeutics in All-Stock Transaction (March 25, 2024)
- Abbvie To Acquire Landos Biopharma, Further Strengthening Its Portfolio In Inflammatory And Autoimmune Diseases (March 25, 2024)
- Bristol Myers Squibb completes acquisition of Karuna Therapeutics, Inc. to strengthen its neuroscience portfolio (March 18, 2024)
- Novo Holdings to Acquire Catalent (February 5, 2024)
Who to call at Branded Legacy, and when
When Branded Legacy changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Branded Legacy raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Branded Legacy, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Branded Legacy. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Branded Legacy makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Frequently asked
Who acquired Sycamore Biopharma?
Sycamore Biopharma was acquired by Branded Legacy, based in Melbourne. The deal was reported on March 1, 2024. Branded Legacy Inc. (OTC.PK:BLEG), is a forward-thinking biotechnology company committed to driving innovation in plant-derived medicines and biotechnological breakthroughs. Branded Legacy is privately held and operates in Manufacturing.
When did Branded Legacy acquire Sycamore Biopharma?
Branded Legacy's acquisition of Sycamore Biopharma was reported on March 1, 2024. Branded Legacy, Inc., a leading BioTech holdings company, has announced the signed letter of intent to purchase Sycamore BioPharma, LLC, a developer of plant-based pharmaceuticals. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Sycamore Biopharma do?
Sycamore BioPharma, LLC is an established developer of plant-based pharmaceuticals with a reputation for offering a meticulously curated line of wellness solutions. It is privately held, operating in Biotechnology, and is based in Canal Name Not Available.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.